abstract |
The invention relates to a composition, comprising (a) a polyolefin; and (b) a compound or formulation having an antiviral and antibacterial function 5 wherein such composition has an increased antiviral rate for H1N1, antiviral rate for Sars-Cov-2, antibacterial rate for E-Coli, and/or antibacterial rate for S.Aureaus, preferably a polyethylene composition. |